Table 3.
Survival
| N (%) | |
|---|---|
| Surveys | |
| KPS | 12 (71) |
| ECOG | 8 (47) |
| Tokuhashi | 3 (18) |
| Tomita | 3 (18) |
| Bauer | 1 (6) |
| Ongoing Clinical Trials | |
| ECOG/Zubrod | 15 (48) |
| KPS | 11 (35) |
Survival
| N (%) | |
|---|---|
| Surveys | |
| KPS | 12 (71) |
| ECOG | 8 (47) |
| Tokuhashi | 3 (18) |
| Tomita | 3 (18) |
| Bauer | 1 (6) |
| Ongoing Clinical Trials | |
| ECOG/Zubrod | 15 (48) |
| KPS | 11 (35) |